Transferring Research From Lab to Market

Fraunhofer USA, Inc., a legally independent US affiliate founded by Fraunhofer-Gesellschaft, is an R&D organization working with industry, universities, and state and federal governments on contract research projects. We are in the high-tech problem solving business; we utilize our world class scientific and engineering expertise to respond to technical problems, to design and develop prototypes, to develop and proof the manufacturing processes, to bridge the gap between basic research and market moving new developments along the technology readiness scale. These translational activities allow our customers to have a positive societal impact.

 

Learn More About How to Work with Us

Fraunhofer-Gesellschaft Latest News

1.9.2022

Proxidrugs in the fight against pathogenic proteins

Cells have an efficient waste disposal system. Proxidrugs utilize this system as part of new treatments for cancer, infections and Alzheimer’s disease. Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP are working with partners to develop this new drug class.
Read more

1.9.2022

Algorithms for manufacturing mRNA-based pharmaceuticals

Back in 2019, BioNTech was far from a household name. Nowadays, however, the pharmaceutical company from Mainz is world-famous for developing and producing Comirnaty©, a COVID-19 vaccine. The company’s original aim was to develop personalized mRNA-based treatments to fight cancer – a goal that it continues to pursue to this day. Since 2016, a research team at the Fraunhofer Institute for Industrial Mathematics ITWM has collaborated with BioNTech to optimize the planning, management and documentation of their production processes. This work culminated in the development of two software platforms, one for vaccines and one for cancer treatments, which help organize and optimize the production processes at BioNTech today. These systems are in use and are continuously adapted and improved as situations and requirements change.
Read more

1.9.2022

Green adhesives made from whey

In collaboration with TU Dresden, Fraunhofer researchers have developed a process for obtaining valuable, high-purity ethyl acetate from whey. This can be used, for example, to produce environmentally friendly adhesives, thereby replacing conventional ethyl acetate extracted from fossil-based raw materials. It also eliminates the need for costly disposal of the molasses produced during whey processing.
Read more

1.9.2022

Out with the silver, in with the copper: A new boost for solar cell production

The rising price and low availability of raw materials, especially silver, are leading to higher costs in producing photovoltaic modules. Fraunhofer researchers have developed an electroplating process that involves substituting silver, an expensive precious metal, with copper, which is more readily available. They have also succeeded in replacing the polymers that are usually left over after electroplating processes, and are expensive to dispose of, by instead using easily recyclable aluminum for masking. In order to bring the technology to the market more quickly, the spin-off PV2+ was launched.
Read more
 

Fraunhofer USA Focus 2021

The Annual Fraunhofer USA Focus provides an in-depth

insight into the latest developments and

research at Fraunhofer USA.

Fraunhofer Media and Press

Press and Media content from Fraunhofer-Gesellschaft Headquarter in Munich 

 

Fraunhofer Media and Press

 

Fraunhofer USA

Fraunhofer USA Headquarters

44792 Helm Street

Plymouth MI, 48170 USA

Phone: +1 734-354-4335

 

Fraunhofer USA Programs

Fraunhofer USA programs help us to accomplish our mission of providing cutting edge technologies to companies and organizations of all sizes.

 

Come Meet Us

Fraunhofer USA participates in conferences and tradeshows. Please come visit us to learn more.